Today@Dal

Evaluating An Investigational Medication Through Clinical Research
A Study For Adults With Asthma Is Now Enrolling!

The purpose of this study is to evaluate the safety and effectiveness of an investigational medication in asthmatic patients.
 
You may be eligible to participate if you:
● You are 18 to 65 years of age
● You have been diagnosed with asthma for at least six months
● Your asthma symptoms worsen when you have a cold
● You have a body mass index (BMI) of 19 to 40 kg/m2 inclusive
 
Other criteria will be assessed by the study doctor if you decide you want to participate.
 
All study-related office visits, medical examinations, and study medication will be provided to qualified study participants at no cost. Compensation for time and travel may be provided.
 
We encourage you to discuss study participation with your physician, family, and friends.
 
For more information, please contact:
Cathy Brown tel (902) 470-7015
Email Catherine.Brown@iwk.nshealth.ca
www.vaccineresearch.ca